Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Biomerica (BMRA) stocks in Canada

Learn how to easily invest in Biomerica stocks.

Biomerica is a medical devices business based in the US. Biomerica stocks (BMRA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.21 – a decrease of 15.69% over the previous week. Biomerica employs 66 staff and has a trailing 12-month revenue of around $14.6 million.

How to buy stocks in Biomerica

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BMRA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biomerica stock price (NASDAQ:BMRA)

Use our graph to track the performance of BMRA stocks over time.

Biomerica shares at a glance

Information last updated 2022-05-12.
Latest market close$3.01
52-week range$2.66 - $7.38
50-day moving average $4.00
200-day moving average $4.37
Wall St. target price$13.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.28

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs

Compare up to 4 providers

Online stock trading

Is it a good time to buy Biomerica stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Biomerica price performance over time

Historical closes compared with the close of $3.01 from 2022-05-13

1 week (2022-05-05) -19.73%
1 month (2022-04-13) -30.32%
3 months (2022-02-16) -31.12%
6 months (2021-11-16) -36.23%
1 year (2021-05-14) -15.21%
2 years (2020-05-15) -59.32%
3 years (2019-05-16) 33.78%
5 years (2017-05-16) 14.45%

Biomerica financials

Revenue TTM $14.6 million
Gross profit TTM $496,981
Return on assets TTM -14.25%
Return on equity TTM -34.45%
Profit margin -23.98%
Book value $0.76
Market capitalisation $35.8 million

TTM: trailing 12 months

Biomerica share dividends

We're not expecting Biomerica to pay a dividend over the next 12 months.

Have Biomerica's shares ever split?

Biomerica's shares were split on a 1:2 basis on 13 November 1994. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biomerica shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Biomerica shares which in turn could have impacted Biomerica's share price.

Biomerica share price volatility

Over the last 12 months, Biomerica's shares have ranged in value from as little as $2.66 up to $7.38. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -0.675. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.

Biomerica overview

Biomerica, Inc. , a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site